These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12003097)

  • 21. Quantitative Poincaré plot analysis of heart rate variability: effect of endurance training.
    Mourot L; Bouhaddi M; Perrey S; Rouillon JD; Regnard J
    Eur J Appl Physiol; 2004 Jan; 91(1):79-87. PubMed ID: 12955518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative beat-to-beat analysis of heart rate dynamics during exercise.
    Tulppo MP; Mäkikallio TH; Takala TE; Seppänen T; Huikuri HV
    Am J Physiol; 1996 Jul; 271(1 Pt 2):H244-52. PubMed ID: 8760181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of sympathoinhibition by imidazolines.
    Szabo B; Urban R
    Ann N Y Acad Sci; 1995 Jul; 763():552-65. PubMed ID: 7677373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlations between the Poincaré plot and conventional heart rate variability parameters assessed during paced breathing.
    Guzik P; Piskorski J; Krauze T; Schneider R; Wesseling KH; Wykretowicz A; Wysocki H
    J Physiol Sci; 2007 Feb; 57(1):63-71. PubMed ID: 17266795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased sympathetic nervous system activity and its therapeutic reduction in arterial hypertension, portal hypertension and heart failure.
    Esler M; Kaye D
    J Auton Nerv Syst; 1998 Oct; 72(2-3):210-9. PubMed ID: 9851571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of the receptor involved in the central hypotensive effect of rilmenidine and moxonidine.
    Bock C; Niederhoffer N; Szabo B
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):262-71. PubMed ID: 10344524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic administration of moxonidine suppresses sympathetic activation in a rat heart failure model.
    Van Kerckhoven R; van Veen TA; Boomsma F; Saxena PR; Schoemaker RG
    Eur J Pharmacol; 2000 May; 397(1):113-20. PubMed ID: 10844105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. I1-imidazoline-receptor agonists in the treatment of hypertension: an appraisal of clinical experience.
    Ollivier JP; Christen MO
    J Cardiovasc Pharmacol; 1994; 24 Suppl 1():S39-48. PubMed ID: 7533226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of the sympathoinhibition produced by the clonidine-like drugs rilmenidine and moxonidine.
    Szabo B; Bock C; Nordheim U; Niederhoffer N
    Ann N Y Acad Sci; 1999 Jun; 881():253-64. PubMed ID: 10415923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the centrally acting agent clonidine on circulating catecholamines at rest and during exercise. Comparison with the effects of beta-blocking agents.
    Mäurer W; Hausen M; Krämer B; Kübler W
    Chest; 1983 Feb; 83(2 Suppl):366-9. PubMed ID: 6129951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sympathoexcitation of moxonidine in the caudal ventrolateral medulla is dependent on I1-imidazoline receptors in anesthetized rats.
    Wang LG; Gao L; Wang W; Yuan WJ; Wang WZ
    Neurosci Lett; 2007 Oct; 426(2):91-6. PubMed ID: 17889438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of sustained-release moxonidine, an imidazoline agonist, on plasma norepinephrine in patients with chronic heart failure.
    Swedberg K; Bristow MR; Cohn JN; Dargie H; Straub M; Wiltse C; Wright TJ;
    Circulation; 2002 Apr; 105(15):1797-803. PubMed ID: 11956122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of moxonidine on putative sympathetic neurons in the rostral ventrolateral medulla of the rat.
    Granata AR
    Neurosignals; 2004; 13(5):241-7. PubMed ID: 15305091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Moxonidine: a new antiadrenergic antihypertensive agent.
    Prichard BN; Graham BR; Owens CW
    J Hypertens Suppl; 1999 Aug; 17(3):S41-54. PubMed ID: 10489098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Moxonidine displays a presynaptic alpha-2-adrenoceptor-dependent synergistic sympathoinhibitory action at imidazoline-1 receptors.
    Schäfer U; Burgdorf C; Engelhardt A; Raasch W; Kurz T; Richardt G
    Ann N Y Acad Sci; 2003 Dec; 1009():265-9. PubMed ID: 15028597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heart rate variability and autonomic activity at rest and during exercise in various physiological conditions.
    Perini R; Veicsteinas A
    Eur J Appl Physiol; 2003 Oct; 90(3-4):317-25. PubMed ID: 13680241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consecutive ultra-short-term heart rate variability to track dynamic changes in autonomic nervous system during and after exercise.
    Chen X; Yao R; Yin G; Li J
    Physiol Meas; 2017 Jun; 38(7):1384-1395. PubMed ID: 28640758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of post exercise hypotension and sympathoinhibition in normal subjects: additional evidence for increased sympathetic outflow in borderline hypertension.
    Floras JS; Senn BL
    Can J Cardiol; 1991; 7(6):253-8. PubMed ID: 1893302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Why imidazoline receptor modulator in the treatment of hypertension?
    Schäfer SG; Kaan EC; Christen MO; Löw-Kröger A; Mest HJ; Molderings GJ
    Ann N Y Acad Sci; 1995 Jul; 763():659-72. PubMed ID: 7677385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of submaximal exercise on blood rheology and sympathetic nerve activity.
    Ikeda N; Yasu T; Tsuboi K; Sugawara Y; Kubo N; Umemoto T; Arao K; Kawakami M; Momomura S
    Circ J; 2010 Apr; 74(4):730-4. PubMed ID: 20190425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.